Articles Archives - Page 383 of 714

FridayJun 25, 2021 12:15 pm

Vivos Therapeutics Inc. (NASDAQ: VVOS) Founder and Chief Medical Officer Shares Company’s Groundbreaking Work in New Book

Dr. Dave Singh, Vivos Therapeutics Inc. founder and Chief Medical Officer, releases his new book titled Pneumopedics and Craniofacial Epigenetics The book is the product of Dr. Singh’s years of research and is a chronology of Vivo Therapeutics’ strides in innovation The book mainly covers craniofacial growth and developmental Genetics It also highlights the relationship between dentofacial anomalies and developmental deficiencies associated with downstream conditions such as Obstructive Sleep Apnea (“OSA”) Since its inception, Vivos Therapeutics (NASDAQ: VVOS) has been a trailblazer in diagnosing and treating mild-to-moderate Obstructive Sleep Apnea (“OSA”). Its main product — Vivos System — results from…

FridayJun 25, 2021 11:50 am

Knightscope Autonomous Security Robot Gets Exposure Boost in Disney+ Episode of ‘Loki’ Series

Knightscope develops and manufactures autonomous security robots that utilize an array of technological tools to patrol and monitor client properties on a 24/7 basis The company’s robots have provided more than a million hours of service to clients since 2015, and recently got high-profile attention through an appearance on the Disney+ streaming superhero series “Loki” Knightscope’s ASR robots are dedicated to helping make the United States safer as a whole, providing video and audio data reception, transmission and analysis, to determine if security concerns and the need for crime deterrence or other emergency intervention are present When Knightscope's K5 model…

FridayJun 25, 2021 11:41 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Discusses Its Vision for Addressing Patient Needs

In 2021, Tryp Therapeutics plans on expanding its academic collaborations It also plans to initiate Phase 2a clinical studies for its synthetic psilocybin drug product as a way to determine efficacy in patient populations Tryp Therapeutics is constantly working on identifying alternative and better ways to control doses and control the patient experience in their dissociative state, mainly through innovations in drug formulation and delivery A primary objective of the administration of psilocybin is to increase the neuroplasticity of the brain Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) recently shed light on its operations and the vision that it has both…

FridayJun 25, 2021 11:04 am

Chalice Brands (CSE: CHAL) (OTCQB: CHALF) Article Shares Insight into Cannabis as a Heat-Relief Option

Magazine article plugs cooling-off benefits of cannabis. Science actually points to different physiological mechanisms that allow cannabis to help lower body temperatures. The cannabis cooling article is only one of several offerings in the summer issue of the Chalice magazine. With record heat engulfing the West for the past couple of weeks and temperatures topping 100 degrees in California, Oregon, Arizona, Nevada and Utah (https://ibn.fm/Und6A), people are searching for relief. Chalice Brands (CSE: CHAL) (OTCQB: CHALF) has an answer: Beat the heat this summer with temperature-fighting cannabis. According to a Chalice magazine article, titled “Cannabis Is Really Cool,” there is…

FridayJun 25, 2021 10:37 am

Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) to Benefit from Surge in Silver Investment Demand

Silver prices rose by 29% YoY in 2020, led by an 8% increase in physical investment demand The World Silver Survey 2021 has forecast total silver demand to rise by 15% in 2021 to 1.03 billion ounces, with industrial silver consumption set to bounce back by 8% YoY The rosy demand outlook contrasts against silver’s tenuous supply profile, with annual mining production declining for a fourth consecutive year in 2020 Excellon Resources is among the leaders in the search for new silver deposits, with a precious metals growth pipeline that includes: Platosa, Mexico’s highest-grade silver mine since production commenced in…

FridayJun 25, 2021 9:00 am

Grapefruit USA Inc. (GPFT) Provides Status Update on Joint Venture, Possible Acquisition

Earlier this year, Grapefruit was approached by a Canadian cannabis company about a potential acquisition. A series of events have delayed the process. Final decisions, details should be discussed in the next 30–60 days. Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed, California-based cannabis company, is providing clarification regarding its previously announced potential acquisition transaction by a Canadian cannabis company (https://ibn.fm/g8yCF). Earlier this year, Grapefruit announced that it had been approached by a Canadian cannabis company to enter into discussions concerning a potential acquisition transaction (https://ibn.fm/FitM6). At the time, Grapefruit CEO Bradley J. Yourist noted that "Grapefruit is not surprised…

ThursdayJun 24, 2021 3:34 pm

Hero Technologies Inc. (HENC) Moves to Strengthen Position in Billion-Dollar Market

Sales milestone represents licensees’ ability to successfully support a safe, accessible and effective adult-use industry Billion-dollar mark was reached despite 60-day shutdown of recreational cannabis industry due to COVID-19 Earlier this year, Hero Technologies formed MassCannabis to explore potential opportunities, projects in the state Late last year, the nonmedical cannabis market in Massachusetts hit a significant milestone: $1 billion in sales since the state voted to legalize the substance — this even though the state was one of only a handful that closed cannabis shops for a period of time because of COVID-19 (https://ibn.fm/HaVli). Sales in the space have continued…

ThursdayJun 24, 2021 3:27 pm

Vegan Sport Icon Venus Williams and PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Committed to Creating Plant-Based Ecosystem; Empower Consumers to Embrace Plant-Based Living

Venus Williams has demonstrated that a plant-based lifestyle can bring health benefits even for those with a physically demanding lifestyle, such as high-performance athletes PlantX and Williams teamed up to help company's community adopt and maintain a plant-based lifestyle PlantX committed to becoming a plant-based market leader; demonstrates the ability to engage influential public figures and create a community around wholesome, healthy living Collaboration between PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) and Venus Williams is one of the powerful alignment of core values. As someone who has overcome considerable health barriers in her sports journey with the help…

ThursdayJun 24, 2021 3:21 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Targets Anxiety Disorders in Focus of Proprietary Psychedelic Treatments

Decision represents opportunity to help millions suffering from social, generalized anxiety disorders Global markets will reach an estimated $4 billion this year, with significant growth projected looking forward WHO estimates that 1 in 13 adults globally suffer from anxiety; treatment options have slow onset, undesirable side effects Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has identified social anxiety disorder, or SAD, and generalized anxiety disorder, or GAD, as the initial target indications for its proprietary psychedelic molecule CYB004 (https://ibn.fm/BQdjY). Collectively, the two global markets will reach an estimated $4 billion this year, with significant…

Site Search

Company Search

Category: Articles